Literature DB >> 3356466

Purification of serotype I antigen from nutritionally variant streptococci.

M George1, I van de Rijn.   

Abstract

The nutritionally variant streptococci (NVS) are a fastidious group of bacteria first recognized in the early 1960s in the blood cultures of patients with subacute bacterial endocarditis. Since that time, the NVS have been implicated in 5 to 6% of all cases of human bacterial endocarditis. The NVS possess membrane-associated amphipathic molecules different from those described for other streptococci. Unitl recently, chemical characterization of these new amphipathic polymers was hampered by unsuccessful attempts at isolating large quantities of these molecules in a form free from other bacterial components. Presently, stationary-phase-culture supernatants provide an optimum source of crude material for amphiphile purification procedures. Hydrophobic-interaction chromatography in conjunction with immunoaffinity chromatography yields an NVS serotype I amphiphile preparation free of contaminants, as determined by immunoelectrophoretic and chemical analyses. Tandem crossed immunoelectrophoresis of the purified extracellular NVS amphiphile demonstrated that it is immunologically similar to the intracellular amphiphile. Finally, this amphiphile serves as the NVS serotype I antigen.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3356466      PMCID: PMC259792          DOI: 10.1128/iai.56.5.1222-1231.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  TEICHOIC ACID AND THE GROUP ANTIGEN OF LACTIC STREPTOCOCCI (GROUP N).

Authors:  S D ELLIOTT
Journal:  Nature       Date:  1963-12-21       Impact factor: 49.962

2.  Bacteremia and endocarditis caused by satelliting streptococci.

Authors:  L R McCarthy; E J Bottone
Journal:  Am J Clin Pathol       Date:  1974-05       Impact factor: 2.493

3.  Synthesis and assembly of bacterial membrane components. A lipopolysaccharide-phospholipid-protein complex excreted by living bacteria.

Authors:  L Rothfield; M Pearlman-Kothencz
Journal:  J Mol Biol       Date:  1969-09-28       Impact factor: 5.469

4.  Studies on the group F antigen of lactobacilli: detection of antibodies by haemagglutination.

Authors:  M J Hewett; K W Knox; A J Wicken
Journal:  J Gen Microbiol       Date:  1970-03

5.  Bacterial persistence in streptococcal endocarditis due to thiol-requiring mutants.

Authors:  P Cayeux; J F Acar; Y A Chabbert
Journal:  J Infect Dis       Date:  1971-09       Impact factor: 5.226

6.  Vitamin B6-dependent Streptococcus mitior (mitis) isolated from patients with systemic infections.

Authors:  R B Carey; K C Gross; R B Roberts
Journal:  J Infect Dis       Date:  1975-06       Impact factor: 5.226

7.  The isolation of symbiotic streptococci.

Authors:  R H George
Journal:  J Med Microbiol       Date:  1974-02       Impact factor: 2.472

8.  Formation of extracellular lipoteichoic acid by oral streptococci and lactobacilli.

Authors:  J L Markham; K W Knox; A J Wicken; M J Hewett
Journal:  Infect Immun       Date:  1975-08       Impact factor: 3.441

9.  Purification of lipoteichoic acids by using phosphatidyl choline vesicles.

Authors:  L J Silvestri; R A Craig; L O Ingram; E M Hoffmann; A S Bleiweis
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

10.  New approaches for the laboratory recognition of M types of group A streptococci.

Authors:  J Rotta; R M Krause; R C Lancefield; W Everly; H Lackland
Journal:  J Exp Med       Date:  1971-11-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Nutritionally variant streptococci.

Authors:  K L Ruoff
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

2.  Immunoblotting and culture positive endocarditis.

Authors:  I Clark; J P Burnie
Journal:  J Clin Pathol       Date:  1991-02       Impact factor: 3.411

3.  Purification and characterization of Streptococcus adjacens (nutritionally variant Streptococcus serotype II) group antigen.

Authors:  P A Sieling; I van de Rijn
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.